Patient Engagement Collaborative

Expert Meetings

Overview

The Patient Engagement Collaborative (PEC) is a joint project between the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI). The PEC is an ongoing, shared setting in which the patient community (PEC members), FDA, and CTTI discuss many topics for improving communication, education, and patient engagement related to medical product regulation. Click here to review the PEC Framework.

Current members of the PEC include:

*indicates new member in 2024

News

Use Case